Ryan Charles S.
Reporting Owner SEC Filing List

CIK: 0001624830
FormFilerSubject CompanyFiling AgentDateActions
3Initial statement of beneficial ownershi...Polaryx Therapeutics, Inc.Edgaragents Llc /fa01/29/2026
3Initial statement of beneficial ownershi...Ryan Charles S.Edgaragents Llc /fa01/29/2026
4Statement of changes in beneficial owner...Quince Therapeutics, Inc.Dorsey & Whitney Llp /fa/01/23/2026
4Statement of changes in beneficial owner...Ryan Charles S.Dorsey & Whitney Llp /fa/01/23/2026
4Statement of changes in beneficial owner...Quince Therapeutics, Inc.Dorsey & Whitney Llp /fa/06/23/2025
4Statement of changes in beneficial owner...Ryan Charles S.Dorsey & Whitney Llp /fa/06/23/2025
4Statement of changes in beneficial owner...Ryan Charles S.Sec Connect /fa08/22/2024
4Statement of changes in beneficial owner...Quince Therapeutics, Inc.Sec Connect /fa02/02/2024
4Statement of changes in beneficial owner...Ryan Charles S.Sec Connect /fa02/02/2024
3Initial statement of beneficial ownershi...Quince Therapeutics, Inc.Donnelley Financial Solutions File16 /fa09/06/2023
Load More

Ryan Charles S. 's Ownership Transactions

IssuerFiling
Date
Transaction
Date
Transaction
Type
SharesPriceTotal AmtShares Owned